MeSH tree: D13.444.308.425.500
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators ...
Jul 22, 2025
0
41
Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumors from ...
Jun 19, 2025
0
33
Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.
Jun 1, 2025
0
28
A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative synthesis of the use of liquid biopsy in gynecological oncology, placing this emerging tool at the forefront ...
May 9, 2025
0
20
Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient (dMMR) early-stage solid cancers who had detectable circulating ...
Apr 29, 2025
0
15
Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer. Their feasibility study suggests that a personalized blood test ...
Apr 24, 2025
0
9
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Apr 15, 2025
0
23
New research has looked into a comprehensive and structured approach to genetic testing, matching children and young people with cancer to targeted treatments. The study aimed to advance precision medicine in the UK to help ...
Feb 28, 2025
0
11
Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of non-invasive cancer detection methods, with significant implications for personalized medicine.
Feb 20, 2025
0
14
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to ...
Jan 27, 2025
0
37
